hodgkin lymphoma
Showing NaN - NaN of 13
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Letermovir
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Participated in Children's Oncology Group Studies
Recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- Assessment of Therapy Complications
- Questionnaire Administration
-
Birmingham, Alabama
- +163 more
Sep 6, 2022
Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)
Recruiting
- Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- AB-205
- Placebo
-
Duarte, California
- +20 more
Aug 2, 2022
Survivors of Transplant, CREST Study
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bioelectric Impedance Analysis
- +7 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Mar 7, 2022
Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial in United States (AB-205)
Completed
- Hodgkin Lymphoma
- Non-hodgkin Lymphoma
- AB-205
-
Duarte, California
- +8 more
Mar 1, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Hodgkin Lymphoma Trial in United States (brentuximab vedotin, nivolumab)
Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United Kingdom, United States (Camidanlumab tesirine)
Completed
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Camidanlumab tesirine
-
Duarte, California
- +11 more
Jul 12, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Withdrawn
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
- +2 more
-
Duarte, California
- +2 more
Nov 19, 2018